Tag - Myomo

Ottobock Signs Distribution Agreement With Myomo

Ottobock, a market leader in technical orthopedics, and Myomo, Inc., a manufacturer of myoelectric orthotics, have reached an agreement for Ottobock to exclusively distribute the Myomo patented MyoPro orthosis technology globally, starting with select markets in North America and Germany. Read more >>

Myomo Wants to Help Brain Injury Survivors Overcome Paralysis

For those who experience a stroke or traumatic brain injury, some are left with having to cope and adapt to having a paralyzed or weak limb. According to Cleveland Clinic, patients who have a left-brain stroke may experience paralysis on the right side of their body. Also, as stated by the National Stroke Association, as many as 9 out of 10 stroke survivors have some degree of paralysis immediately following a stroke. Myomo, a medtech company, is working to […]

Medical Robotics Firm Myomo Explores Going Public

Myomo, Inc., a commercial-stage medical robotics company whose products enable users to overcome upper extremity paralysis (www.myomo.com), announced today that it has confidentially submitted a Form 1-A with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock under the recently amended provisions of Regulation A pursuant to the Jumpstart Our Business Startups (JOBS) Act of 2012. The number of shares to be offered and the price range for the proposed offering […]

Medical robotics firm treating upper extremity paralysis explores going public

Cambridge, Massachusetts-based Myomo announced Friday that it is taking advantage of new SEC provisions that allow early-stage companies to raise capital without restricting it to only accredited investors
Through the Regulation A+ provision, which is an amendment to Regulation A, the Securities & Exchange Commission adopted rules that went into effect June 2015 allowing early-stage companies to raise a maximum of $50 million from the public. They are known as mini-IPOs and mark a pivotal moment given the agency accepted equity […]

Myomo registers for IPO

Myomo said today it filed with the SEC for an initial public offering, looking to register on the NYSE under the ticker symbol “MYO”.
Myomo develops and produces myoelectric orthotics for patients with neuromuscular disorders, including its flagship MyoPro line. The orthosis devices are non-invasive, powered braces used to support weak or deformed arms and hands to allow for functional activity. Read more >>